Voyageur Pharmaceuticals (CVE:VM) Stock Price Down 31.3% – Should You Sell?

Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM) were down 31.3% during mid-day trading on Thursday . The stock traded as low as C$0.14 and last traded at C$0.17. Approximately 1,643,425 shares traded hands during trading, an increase of 198% from the average daily volume of 550,572 shares. The stock had previously closed at C$0.24.

Voyageur Pharmaceuticals Price Performance

The stock has a market capitalization of C$25.10 million, a P/E ratio of -18.00 and a beta of 0.32. The company has a 50 day moving average of C$0.11 and a 200-day moving average of C$0.08. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21.

Voyageur Pharmaceuticals Company Profile

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.